News

A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad's appointment might mean for approvals in rare ...
At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change ...
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...
WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...
The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.
Axon named Tina Hahn as president and managing partner. Bristol Myers Squibb promoted Cari Gallman to EVP, general counsel ...
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...
FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...
With a demand that vaccine boosters be tested against placebos, RFK Jr. puts an old antivaccine claim at the forefront of government health policy.